An ultrasound paired with a blood test leads to a 40% improvement in cancer diagnoses, especially when it comes to liver cancer.
Ads by Google
New research gives alcoholics another good reason to quit their drinking habit in 2018. Alcohol directly damages your DNA, and if that weren’t bad enough, it also increases your cancer risk. These are the consequences of a toxic chemical produced during your body’s attempt to process alcohol.
Research indicates that baking soda can remove as much as 96% of pesticides from our fruits and vegetables. Buying organic produce would still be the best option, but if you’re struggling to eat 100% organic this handy trick will be a big help.
According to cancer.net, Liver Cancer is the 10th most common cancer and the 5th most common cause of cancer death among men. It is also the 8th most common cause of cancer death among women. Mainstream treatments vary from surgery, chemotherapy or radiation. But what if there were natural remedies, scientifically proven, to kill liver cancer cells? Well, there are, and to find out more about 3 vegan remedies that can kill liver cancer cells, read on.
Yesterday was a big day for the people looking for liver cancer treatment new options as FDA expanded the indications of Bayer's Regorafenib (Stivarga) to include the treatment of patients with liver cancer who have until now been treated with Sorafenib.
GMO Insulin Shuts Down The Pancreas In Type 2 Diabetes Escalating Patients To Type 1, But You Can Avoid It
GMO Insulin has been shown to accelerate Type 2 Diabetes to Type 1 Diabetes, a study finds.
Researchers say if you think that binge drinking is safer for your liver than regular heavy drinking than perhaps you should stop and think this over again.
People who drink three or more alcoholic beverages per day could be increasing their chances of developing liver cancer.
Nexavar becomes the first FDA-approved drug treatment therapy for patients suffering from liver cancer. Nexavar is made by Bayer Healthcare and the FDA liver cancer treatment node was announced today.
Progen Pharmaceuticals awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence the Phase 3 program as rapidly as possible, the Company will no longer continue with the Special Protocol Assessment process.